BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 25823825)

  • 1. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.
    Kinugasa H; Nouso K; Miyahara K; Morimoto Y; Dohi C; Tsutsumi K; Kato H; Matsubara T; Okada H; Yamamoto K
    Cancer; 2015 Jul; 121(13):2271-80. PubMed ID: 25823825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
    Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
    Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
    Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
    Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
    Ogura T; Yamao K; Hara K; Mizuno N; Hijioka S; Imaoka H; Sawaki A; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    J Gastroenterol; 2013 May; 48(5):640-6. PubMed ID: 22983505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
    Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
    Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
    Brychta N; Krahn T; von Ahsen O
    Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
    Ako S; Nouso K; Kinugasa H; Dohi C; Matushita H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H; Okada H
    Pancreatology; 2017; 17(2):285-290. PubMed ID: 28139399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
    Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.
    Cheng H; Liu C; Jiang J; Luo G; Lu Y; Jin K; Guo M; Zhang Z; Xu J; Liu L; Ni Q; Yu X
    Int J Cancer; 2017 May; 140(10):2344-2350. PubMed ID: 28205231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
    Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
    Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.
    Jiao L; Zhu J; Hassan MM; Evans DB; Abbruzzese JL; Li D
    Pancreas; 2007 Jan; 34(1):55-62. PubMed ID: 17198183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.